Can I get it?
Yes, if a doctor decides it is right for you. Compounded melasma formula is prepared to prescription by a compounding pharmacy after a medical review; allow a few days for it to be made.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in France. Consultation €35, refunded if the doctor decides it is not safe to prescribe.

Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
Compounded melasma formula is used in weight management. Whether it suits you depends on your medical history, your other medicines and your goals — which is exactly what a consultation is for.
Compounded melasma formula is a magistral preparation: its components are authorised medicines in the EU, and a compounding pharmacy combines them to a licensed doctor's prescription. The combination itself is not a licensed product.
Yes, if a doctor decides it is right for you. Compounded melasma formula is prepared to prescription by a compounding pharmacy after a medical review; allow a few days for it to be made.
Our doctors review every Dermatology option and recommend what fits your history and goals.
See all Dermatology optionsEvery trial behind Compounded melasma formula is listed below with how many people took part and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Yes. People in París, France, can request an online doctor consultation about Compounded melasma formula with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the EU prescription arrives as a PDF for a pharmacist in France, who dispenses the locally marketed equivalent containing Melasma-combination-formula.
Availability
Compounded melasma formula is available to residents of France through the online consultation. A prescription follows only if the doctor approves it.
How the EU prescription works where you are: In France, show the approved prescription PDF to a pharmacist. They honour it under EU cross-border rules and dispense the locally marketed equivalent containing Melasma-combination-formula.
VERIFIED EVIDENCE
WHAT IT IS
A Kligman-type compounded cream in which low-strength tretinoin increases the penetration and effect of hydroquinone, with kojic acid and niacinamide adding tyrosinase inhibition and barrier support.
DEVELOPMENT STAGE
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| Kligman and Willis 1975 (hydroquinone + tretinoin + dexamethasone formula) | Adults with melasma and other hyperpigmentation, open-label | — | Read out | 1975 |
| Taylor 2003 (fixed triple combination vs dual combinations) | Adults with moderate to severe facial melasma, nightly for 8 weeks, two randomised investigator-blind studies | — | Read out | 2003 |
| Chan 2008 (fixed triple combination vs hydroquinone 4%) | Asian adults with moderate to severe melasma, 8 weeks | — | Read out | 2008 |
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| Hydroquinone 4% + tretinoin 0.05% + fluocinolone 0.01%, nightly | 77% reached a melasma severity score of none or mild | 8 |
| Dual combinations (any two of the three) | Lower response than the triple combination | 8 |
The trial product contained a corticosteroid and tretinoin 0.05% used nightly. Our compounded formula uses tretinoin 0.025% with kojic acid and niacinamide instead of a corticosteroid, applied twice a week. The combination has not been studied in that form; component evidence is cited.
| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| Niacinamide 4% cream | 44% good to excellent improvement; fewer side effects than hydroquinone | 8 |
Small split-face study of 27 patients supporting niacinamide as a component, not as a replacement for hydroquinone.
NAMED SAFETY SIGNALS
Tretinoin is contraindicated in pregnancy and in women planning a pregnancy, and hydroquinone is not recommended. Both components are avoided in breastfeeding.
Redness and peeling from tretinoin can, if severe, trigger new pigmentation in melasma-prone skin. This is why the formula is applied only twice a week and stopped for persistent inflammation.
Courses are limited to 3 months with a planned break, and total continuous hydroquinone exposure never exceeds 6 months.
Prepared to prescription by a pharmacy under national magistral rules; stability and shelf life follow the pharmacy's label rather than an EU marketing authorisation.
About
Active ingredient: Melasma-combination-formula · Dosages: Hydroquinone 4% + tretinoin 0.025% + kojic acid 2% + niacinamide 4%
The melasma formula is a magistral night cream combining hydroquinone 4%, tretinoin 0.025%, kojic acid 2% and niacinamide 4%. It follows the principle described by Kligman and Willis in 1975, in which a retinoid increases the penetration and effect of hydroquinone, replacing the original corticosteroid with kojic acid and niacinamide.
Because it is stronger than hydroquinone alone, it is used only two nights a week and only on the patches. A licensed doctor confirms that the pigmentation is melasma, excludes pregnancy, and reviews photographs at 2 months. The combination itself is compounded rather than a licensed product.
How it helps
Hydroquinone and kojic acid reduce the production of new pigment.
Low-strength tretinoin sheds pigmented cells and improves penetration.
Niacinamide reduces pigment transfer and helps the skin tolerate the actives.
What to expect
Apply a thin layer to the patches only, two non-consecutive nights a week, on fully dry skin after cleansing. Wash off in the morning and apply SPF 50+. Never increase the frequency without your doctor's advice.
Formula your doctor can prescribe
Safety first
Compounded melasma formula is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Redness, peeling, dryness and stinging are expected in the first weeks, from the tretinoin and hydroquinone components. Lightening of the surrounding skin can occur if the cream spreads beyond the patch.
Not suitable if you
PRICING
€25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth. €35 one-off is available for sexual health.
ONGOING PLAN
€25/month
Billed €25 every 28 days · cancel anytime
28-day treatment cycle
For ongoing treatment and doctor-reviewed renewals.
Renewals reviewed by your doctor
Full refund if a review is not approved
WHAT'S INCLUDED
ONGOING PLAN
€15/month
Billed €45 every 90 days · cancel anytime
For ongoing treatment and doctor-reviewed renewals.
Lowest monthly price we offer
Full refund if a review is not approved
WHAT'S INCLUDED
ONE-OFF
€35 one-off
One consultation, one doctor, one decision.
Nothing stored publicly, ever
Full refund if a review is not approved
WHAT'S INCLUDED
Full refund if a review is not approved
For a one-off consultation, we refund the €35 consultation fee. For a subscription review, we refund that period's fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
An EU-licensed doctor reads your questionnaire and answers in less than 2 hours on average.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
FREQUENTLY ASKED QUESTIONS
OTHER DERMATOLOGY TREATMENTS
Find out if it's right for you
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.
HI-DOCTOR NEWSLETTER
At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.